title: [Blood plasma as a drug. National evidence-based therapeutic guidelines are missing].
authors.affiliation: Hematologiskt centrum, Karolinska Universitetssjukhuset, Huddinge. jan.palmblad@ki.se
authors.forename: Jan
authors.initials: J
authors.lastname: Palmblad
authors.forename: Hans
authors.initials: H
authors.lastname: Johnsson
authors.forename: Michael
authors.initials: M
authors.lastname: Lagerkranser
authors.forename: Gunilla
authors.initials: G
authors.lastname: Sundelin
authors.forename: Agneta
authors.initials: A
authors.lastname: Wikman
authors.forename: Ulf
authors.initials: U
authors.lastname: Schött
mesh_terms: D016913:Blood Component Transfusion / Q000009:adverse effects / Q000706:statistics & numerical data; D000075202:Contraindications; D019317:Evidence-Based Medicine; D006801:Humans; D010949:Plasma